However, although potency is important, and maintaining the presence of Br seems to be fairly accomplished [25,32], the selectivity between protein-kinase subfamilies is a crucial point to design proper anti-AD drugs, and even anti-cancer drugs. This evidence concerns the gene WEE1 and cancer.